Calophycin
| Internal ID | df2ed6ea-b264-40c7-be3e-0cdbde4b5955 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | 2-[(3R,6R,12R,15R,18R,21R,24S,27R,28R,31S)-3,15-bis(2-amino-2-oxoethyl)-12-(3-amino-3-oxopropyl)-6-[3-(diaminomethylideneamino)propyl]-27-hydroxy-4,21-dimethyl-2,5,8,11,14,17,20,23,26,30-decaoxo-24-propan-2-yl-28-[(2S)-tetradecan-2-yl]-1,4,7,10,13,16,19,22,25,29-decazabicyclo[29.3.0]tetratriacontan-18-yl]acetic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C56H96N16O16/c1-7-8-9-10-11-12-13-14-15-16-19-31(4)45-46(79)53(86)69-44(30(2)3)52(85)64-32(5)47(80)67-36(27-43(77)78)50(83)68-35(26-40(58)74)49(82)66-33(22-23-39(57)73)48(81)63-29-42(76)65-34(20-17-24-62-56(60)61)54(87)71(6)38(28-41(59)75)55(88)72-25-18-21-37(72)51(84)70-45/h30-38,44-46,79H,7-29H2,1-6H3,(H2,57,73)(H2,58,74)(H2,59,75)(H,63,81)(H,64,85)(H,65,76)(H,66,82)(H,67,80)(H,68,83)(H,69,86)(H,70,84)(H,77,78)(H4,60,61,62)/t31-,32+,33+,34+,35+,36+,37-,38+,44-,45+,46+/m0/s1 |
| InChI Key | UAZZFDUYHPLRJY-IXSJMJCZSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C56H96N16O16 |
| Molecular Weight | 1249.50 g/mol |
| Exact Mass | 1248.71902104 g/mol |
| Topological Polar Surface Area (TPSA) | 525.00 Ų |
| XlogP | -1.60 |
| Atomic LogP (AlogP) | -4.14 |
| H-Bond Acceptor | 16 |
| H-Bond Donor | 15 |
| Rotatable Bonds | 26 |
| DTXSID201334593 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4736 | 47.36% |
| Caco-2 | - | 0.8598 | 85.98% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.8143 | 81.43% |
| Subcellular localzation | Lysosomes | 0.5534 | 55.34% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8162 | 81.62% |
| OATP1B3 inhibitior | + | 0.9276 | 92.76% |
| MATE1 inhibitior | - | 0.8400 | 84.00% |
| OCT2 inhibitior | - | 0.7750 | 77.50% |
| BSEP inhibitior | + | 0.8769 | 87.69% |
| P-glycoprotein inhibitior | + | 0.7422 | 74.22% |
| P-glycoprotein substrate | + | 0.8887 | 88.87% |
| CYP3A4 substrate | + | 0.7320 | 73.20% |
| CYP2C9 substrate | - | 0.6112 | 61.12% |
| CYP2D6 substrate | - | 0.8287 | 82.87% |
| CYP3A4 inhibition | - | 0.9599 | 95.99% |
| CYP2C9 inhibition | - | 0.8237 | 82.37% |
| CYP2C19 inhibition | - | 0.8246 | 82.46% |
| CYP2D6 inhibition | - | 0.9077 | 90.77% |
| CYP1A2 inhibition | - | 0.8657 | 86.57% |
| CYP2C8 inhibition | + | 0.7526 | 75.26% |
| CYP inhibitory promiscuity | - | 0.9937 | 99.37% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.6078 | 60.78% |
| Eye corrosion | - | 0.9834 | 98.34% |
| Eye irritation | - | 0.8962 | 89.62% |
| Skin irritation | - | 0.7625 | 76.25% |
| Skin corrosion | - | 0.9110 | 91.10% |
| Ames mutagenesis | - | 0.5237 | 52.37% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6433 | 64.33% |
| Micronuclear | + | 0.7900 | 79.00% |
| Hepatotoxicity | - | 0.5444 | 54.44% |
| skin sensitisation | - | 0.8377 | 83.77% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.7125 | 71.25% |
| Nephrotoxicity | + | 0.4819 | 48.19% |
| Acute Oral Toxicity (c) | III | 0.5563 | 55.63% |
| Estrogen receptor binding | + | 0.7150 | 71.50% |
| Androgen receptor binding | + | 0.6833 | 68.33% |
| Thyroid receptor binding | + | 0.5723 | 57.23% |
| Glucocorticoid receptor binding | + | 0.6247 | 62.47% |
| Aromatase binding | + | 0.7470 | 74.70% |
| PPAR gamma | + | 0.7288 | 72.88% |
| Honey bee toxicity | - | 0.7478 | 74.78% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.6200 | 62.00% |
| Fish aquatic toxicity | - | 0.5149 | 51.49% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.88% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.63% | 96.09% |
| CHEMBL4071 | P08311 | Cathepsin G | 98.45% | 94.64% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 96.71% | 93.00% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 96.54% | 82.38% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 96.24% | 83.82% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 95.77% | 94.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 95.31% | 90.71% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 95.21% | 97.05% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 94.88% | 97.25% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.61% | 90.08% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 94.59% | 95.00% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 94.50% | 90.24% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 94.21% | 100.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 93.50% | 94.66% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 92.90% | 95.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.82% | 96.47% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 92.62% | 90.17% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 92.52% | 95.89% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 92.03% | 97.64% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.72% | 94.45% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 90.27% | 99.17% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 89.85% | 96.11% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 89.24% | 96.31% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 88.97% | 97.43% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 88.70% | 96.90% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 88.52% | 91.81% |
| CHEMBL217 | P14416 | Dopamine D2 receptor | 88.48% | 95.62% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.12% | 91.03% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.05% | 93.56% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.95% | 100.00% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 85.58% | 85.14% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 84.84% | 95.56% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 84.83% | 95.56% |
| CHEMBL1949 | P62937 | Cyclophilin A | 84.73% | 98.57% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.62% | 97.09% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 84.38% | 87.16% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 84.22% | 95.93% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 83.88% | 98.59% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 83.84% | 92.32% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 83.76% | 93.03% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 83.71% | 92.08% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 83.68% | 96.00% |
| CHEMBL228 | P31645 | Serotonin transporter | 83.19% | 95.51% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 82.59% | 98.03% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 82.40% | 97.47% |
| CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 82.33% | 85.83% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 82.31% | 98.00% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 82.22% | 96.38% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.20% | 90.24% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 81.87% | 95.92% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 81.81% | 91.11% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.69% | 99.23% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 81.29% | 86.33% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 80.83% | 82.69% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 80.36% | 97.29% |
| CHEMBL3837 | P07711 | Cathepsin L | 80.25% | 96.61% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683684 |
| LOTUS | LTS0091596 |
| wikiData | Q104203152 |